

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.99606968 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.20323923 |
| 3 | negative T cell selection (GO:0043383) | 6.04548315 |
| 4 | positive thymic T cell selection (GO:0045059) | 6.01503594 |
| 5 | positive T cell selection (GO:0043368) | 5.96490442 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.80192432 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.80192432 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.77129109 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.77129109 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 5.55205522 |
| 11 | negative thymic T cell selection (GO:0045060) | 5.47537187 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.43052104 |
| 13 | T cell selection (GO:0045058) | 5.25982369 |
| 14 | thymic T cell selection (GO:0045061) | 5.14200510 |
| 15 | interferon-gamma production (GO:0032609) | 4.94608398 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.91432005 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.91432005 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.91432005 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.91432005 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.91432005 |
| 21 | modulation by symbiont of host immune response (GO:0052553) | 4.91432005 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.89662720 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.61602083 |
| 24 | response to interleukin-15 (GO:0070672) | 4.49035647 |
| 25 | T cell receptor signaling pathway (GO:0050852) | 4.43479272 |
| 26 | T cell migration (GO:0072678) | 4.34186793 |
| 27 | V(D)J recombination (GO:0033151) | 4.32895338 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.29978717 |
| 29 | detection of other organism (GO:0098543) | 4.26845814 |
| 30 | detection of bacterium (GO:0016045) | 4.20973646 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 4.02508493 |
| 32 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.91187683 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.88666873 |
| 34 | response to peptidoglycan (GO:0032494) | 3.88048156 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.87114155 |
| 36 | T cell costimulation (GO:0031295) | 3.80005817 |
| 37 | activated T cell proliferation (GO:0050798) | 3.79193126 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.75546223 |
| 39 | leukocyte aggregation (GO:0070486) | 3.75194865 |
| 40 | lymphocyte costimulation (GO:0031294) | 3.72523178 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 3.67423532 |
| 42 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57884140 |
| 43 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.57201564 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.54795549 |
| 45 | T cell homeostasis (GO:0043029) | 3.54616095 |
| 46 | respiratory burst (GO:0045730) | 3.52852948 |
| 47 | mast cell activation (GO:0045576) | 3.50649391 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.50567256 |
| 49 | regulation of T cell tolerance induction (GO:0002664) | 3.49565340 |
| 50 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.47680246 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.46450421 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.45820404 |
| 53 | neutrophil activation (GO:0042119) | 3.42647944 |
| 54 | positive regulation of interleukin-2 production (GO:0032743) | 3.41351148 |
| 55 | mast cell degranulation (GO:0043303) | 3.41127388 |
| 56 | mast cell activation involved in immune response (GO:0002279) | 3.41127388 |
| 57 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.40139002 |
| 58 | regulation of regulatory T cell differentiation (GO:0045589) | 3.39585852 |
| 59 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.39548499 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.36144330 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.35862186 |
| 62 | regulation of B cell differentiation (GO:0045577) | 3.34343871 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.33511389 |
| 64 | natural killer cell differentiation (GO:0001779) | 3.31669462 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.29694591 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.28166855 |
| 67 | response to host immune response (GO:0052572) | 3.28166855 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27236715 |
| 69 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26441662 |
| 70 | positive regulation of histone deacetylation (GO:0031065) | 3.25386636 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 3.23950887 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22926182 |
| 73 | germinal center formation (GO:0002467) | 3.22427849 |
| 74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.17988398 |
| 75 | regulation of leukocyte degranulation (GO:0043300) | 3.17546788 |
| 76 | T cell differentiation (GO:0030217) | 3.15220677 |
| 77 | positive regulation of granulocyte differentiation (GO:0030854) | 3.14696092 |
| 78 | granulocyte activation (GO:0036230) | 3.13881352 |
| 79 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.12543834 |
| 80 | positive regulation of tolerance induction (GO:0002645) | 3.12234907 |
| 81 | microglial cell activation (GO:0001774) | 3.10456782 |
| 82 | leukocyte degranulation (GO:0043299) | 3.10065175 |
| 83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.08723568 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.06362552 |
| 85 | ribosomal small subunit assembly (GO:0000028) | 3.03958650 |
| 86 | viral transcription (GO:0019083) | 3.03832475 |
| 87 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.03470640 |
| 88 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.02945892 |
| 89 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.02764497 |
| 90 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.02398826 |
| 91 | lymphocyte homeostasis (GO:0002260) | 3.02237299 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02169919 |
| 93 | response to host (GO:0075136) | 3.01841649 |
| 94 | response to host defenses (GO:0052200) | 3.01841649 |
| 95 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01841649 |
| 96 | positive regulation of isotype switching (GO:0045830) | 3.00994565 |
| 97 | detection of biotic stimulus (GO:0009595) | 3.00824471 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.00500321 |
| 99 | regulation of mast cell activation (GO:0033003) | 3.00476626 |
| 100 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.00180439 |
| 101 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99076694 |
| 102 | regulation of granulocyte differentiation (GO:0030852) | 2.96708049 |
| 103 | defense response to protozoan (GO:0042832) | 2.95705326 |
| 104 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.95286993 |
| 105 | positive regulation of protein deacetylation (GO:0090312) | 2.93524057 |
| 106 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92728047 |
| 107 | alpha-beta T cell activation (GO:0046631) | 2.92714605 |
| 108 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.92416045 |
| 109 | Peyers patch development (GO:0048541) | 2.92416045 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 2.91408267 |
| 111 | megakaryocyte development (GO:0035855) | 2.90857827 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90289442 |
| 113 | sequestering of actin monomers (GO:0042989) | 2.90257196 |
| 114 | macrophage activation (GO:0042116) | 2.89402678 |
| 115 | cell wall macromolecule metabolic process (GO:0044036) | 2.89233601 |
| 116 | cell wall macromolecule catabolic process (GO:0016998) | 2.89233601 |
| 117 | regulation of response to interferon-gamma (GO:0060330) | 2.88843837 |
| 118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88831726 |
| 119 | cellular response to type I interferon (GO:0071357) | 2.88461286 |
| 120 | type I interferon signaling pathway (GO:0060337) | 2.88461286 |
| 121 | response to type I interferon (GO:0034340) | 2.88020938 |
| 122 | B cell mediated immunity (GO:0019724) | 2.87903857 |
| 123 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.86263838 |
| 124 | cellular hyperosmotic response (GO:0071474) | 2.85885600 |
| 125 | translational termination (GO:0006415) | 2.84656666 |
| 126 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.84342106 |
| 127 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.84342106 |
| 128 | cell-cell recognition (GO:0009988) | 2.83487221 |
| 129 | negative regulation of type 2 immune response (GO:0002829) | 2.82731242 |
| 130 | negative regulation of innate immune response (GO:0045824) | 2.82168856 |
| 131 | negative regulation of necroptotic process (GO:0060546) | 2.81613779 |
| 132 | sperm-egg recognition (GO:0035036) | 2.75586115 |
| 133 | acrosome assembly (GO:0001675) | 2.74554405 |
| 134 | tolerance induction (GO:0002507) | 2.74463231 |
| 135 | alpha-beta T cell differentiation (GO:0046632) | 2.73500310 |
| 136 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72907380 |
| 137 | negative regulation of phagocytosis (GO:0050765) | 2.71594265 |
| 138 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.69616775 |
| 139 | natural killer cell activation (GO:0030101) | 2.69251625 |
| 140 | T cell activation (GO:0042110) | 2.67251423 |
| 141 | regulation of necroptotic process (GO:0060544) | 2.67080414 |
| 142 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.65958546 |
| 143 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.65958546 |
| 144 | regulation of tolerance induction (GO:0002643) | 2.64767349 |
| 145 | translational elongation (GO:0006414) | 2.63527436 |
| 146 | regulation of isotype switching (GO:0045191) | 2.60410177 |
| 147 | sperm motility (GO:0030317) | 2.60083044 |
| 148 | cellular response to interleukin-4 (GO:0071353) | 2.58380839 |
| 149 | regulation of defense response to virus by virus (GO:0050690) | 2.58017451 |
| 150 | cellular extravasation (GO:0045123) | 2.57405297 |
| 151 | leukocyte homeostasis (GO:0001776) | 2.57246382 |
| 152 | lymph node development (GO:0048535) | 2.56039828 |
| 153 | endothelial tube morphogenesis (GO:0061154) | 2.54962719 |
| 154 | morphogenesis of an endothelium (GO:0003159) | 2.54962719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.17029065 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.30860156 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.11907327 |
| 4 | * MYC_22102868_ChIP-Seq_BL_Human | 3.76896740 |
| 5 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.86048013 |
| 6 | MYB_26560356_Chip-Seq_TH2_Human | 2.79716030 |
| 7 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.73484237 |
| 8 | MAF_26560356_Chip-Seq_TH1_Human | 2.69518698 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.68852875 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66694397 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.65795393 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60185934 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59385512 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.58730331 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.44203978 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.42360895 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41759433 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.41448375 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36689159 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.36274216 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.31872456 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.30325840 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28601764 |
| 24 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.20234046 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18755074 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18473070 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05755409 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98947219 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96362073 |
| 30 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.94480923 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.94245745 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.93954907 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93130202 |
| 34 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87067606 |
| 35 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.84548105 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82038391 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.79678346 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78797632 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.78596865 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77780905 |
| 41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77686739 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76114895 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75908774 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69737617 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67345957 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65584701 |
| 47 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64327363 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64262655 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63756055 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59471926 |
| 51 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.56021242 |
| 52 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50659483 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49867894 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45684369 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45329924 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45169307 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43935193 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42884724 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42754344 |
| 60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41689165 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40978138 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38062524 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36336370 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36184505 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36013797 |
| 66 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33688497 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32044145 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25552547 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25466868 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24706427 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23223387 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22841329 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22625831 |
| 74 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20002554 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19275940 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16491141 |
| 77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16091333 |
| 78 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.15983768 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15822720 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14809547 |
| 81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12683692 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10670371 |
| 83 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.09299475 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08644448 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05238532 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05097939 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03241168 |
| 88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03130351 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02529152 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02293123 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01958895 |
| 92 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.01146460 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99508720 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97328086 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97161924 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97089132 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97020570 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96962570 |
| 99 | P68_20966046_ChIP-Seq_HELA_Human | 0.95390807 |
| 100 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.95124587 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93307518 |
| 102 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91570847 |
| 103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91173391 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89929846 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89895523 |
| 106 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.89586855 |
| 107 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89308938 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89304463 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88259084 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88186110 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87725348 |
| 112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.87695833 |
| 113 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85806887 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85689427 |
| 115 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85351624 |
| 116 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84616278 |
| 117 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.83153826 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82590627 |
| 119 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.82339390 |
| 120 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81974580 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81673595 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81565426 |
| 123 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.80614650 |
| 124 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80308373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.60839038 |
| 2 | MP0000685_abnormal_immune_system | 3.18949632 |
| 3 | MP0005671_abnormal_response_to | 3.17312810 |
| 4 | MP0002398_abnormal_bone_marrow | 2.75872988 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.73304075 |
| 6 | MP0000703_abnormal_thymus_morphology | 2.71599627 |
| 7 | MP0005410_abnormal_fertilization | 2.69138372 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.67116732 |
| 9 | MP0001800_abnormal_humoral_immune | 2.66140926 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.59443872 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.36059769 |
| 12 | MP0001790_abnormal_immune_system | 2.35993083 |
| 13 | MP0005387_immune_system_phenotype | 2.35993083 |
| 14 | MP0002722_abnormal_immune_system | 2.32440423 |
| 15 | MP0001819_abnormal_immune_cell | 2.31891462 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.28806692 |
| 17 | MP0002723_abnormal_immune_serum | 2.23630521 |
| 18 | MP0000689_abnormal_spleen_morphology | 2.22633233 |
| 19 | MP0000716_abnormal_immune_system | 2.22614138 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 2.17933012 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.12658510 |
| 22 | MP0005451_abnormal_body_composition | 2.11399582 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.09431291 |
| 24 | MP0002405_respiratory_system_inflammati | 2.03805391 |
| 25 | MP0002429_abnormal_blood_cell | 1.95875297 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.95575748 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.95575748 |
| 28 | MP0002006_tumorigenesis | 1.94395903 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.90667620 |
| 30 | MP0009785_altered_susceptibility_to | 1.90371647 |
| 31 | MP0005025_abnormal_response_to | 1.88862195 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.86356337 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.85061438 |
| 34 | MP0003866_abnormal_defecation | 1.73864925 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.72225352 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.71642376 |
| 37 | MP0003436_decreased_susceptibility_to | 1.70643979 |
| 38 | MP0001873_stomach_inflammation | 1.70183452 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.69010025 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.65895122 |
| 41 | MP0002132_abnormal_respiratory_system | 1.64814009 |
| 42 | MP0009278_abnormal_bone_marrow | 1.62599501 |
| 43 | MP0004510_myositis | 1.59960473 |
| 44 | MP0003646_muscle_fatigue | 1.59207735 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.57298322 |
| 46 | MP0004947_skin_inflammation | 1.56952446 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.53989813 |
| 48 | MP0003303_peritoneal_inflammation | 1.47836174 |
| 49 | MP0000490_abnormal_crypts_of | 1.38949360 |
| 50 | MP0003077_abnormal_cell_cycle | 1.38941761 |
| 51 | MP0006082_CNS_inflammation | 1.37991509 |
| 52 | MP0004381_abnormal_hair_follicle | 1.37725918 |
| 53 | MP0002419_abnormal_innate_immunity | 1.36519701 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.35473348 |
| 55 | MP0008057_abnormal_DNA_replication | 1.32407631 |
| 56 | MP0008260_abnormal_autophagy | 1.31817634 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.30672813 |
| 58 | MP0001851_eye_inflammation | 1.30405524 |
| 59 | MP0003111_abnormal_nucleus_morphology | 1.29756964 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.27184688 |
| 61 | MP0003828_pulmonary_edema | 1.25404229 |
| 62 | MP0001853_heart_inflammation | 1.23654590 |
| 63 | MP0002019_abnormal_tumor_incidence | 1.18521525 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.18147508 |
| 65 | MP0004036_abnormal_muscle_relaxation | 1.16276217 |
| 66 | MP0002933_joint_inflammation | 1.14424508 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.13365234 |
| 68 | MP0003724_increased_susceptibility_to | 1.12644950 |
| 69 | MP0005670_abnormal_white_adipose | 1.12150857 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.07910706 |
| 71 | MP0003693_abnormal_embryo_hatching | 1.06860179 |
| 72 | MP0000858_altered_metastatic_potential | 1.06385653 |
| 73 | MP0008877_abnormal_DNA_methylation | 1.06355119 |
| 74 | MP0005330_cardiomyopathy | 1.06223117 |
| 75 | MP0009764_decreased_sensitivity_to | 1.04831317 |
| 76 | MP0004957_abnormal_blastocyst_morpholog | 1.03361690 |
| 77 | MP0001929_abnormal_gametogenesis | 1.01500021 |
| 78 | MP0000749_muscle_degeneration | 1.01167960 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 0.99635014 |
| 80 | MP0008058_abnormal_DNA_repair | 0.99062246 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.98986185 |
| 82 | MP0005174_abnormal_tail_pigmentation | 0.97161885 |
| 83 | MP0004087_abnormal_muscle_fiber | 0.94292842 |
| 84 | MP0000343_altered_response_to | 0.92941086 |
| 85 | MP0004883_abnormal_blood_vessel | 0.92922502 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.90375467 |
| 87 | MP0003690_abnormal_glial_cell | 0.89933815 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87492010 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.86253921 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.85803701 |
| 91 | MP0001663_abnormal_digestive_system | 0.85748223 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.85700032 |
| 93 | MP0008007_abnormal_cellular_replicative | 0.85436097 |
| 94 | MP0000313_abnormal_cell_death | 0.85219878 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.84966859 |
| 96 | MP0004130_abnormal_muscle_cell | 0.84931791 |
| 97 | MP0008469_abnormal_protein_level | 0.84038054 |
| 98 | MP0003698_abnormal_male_reproductive | 0.83204460 |
| 99 | MP0000751_myopathy | 0.83154449 |
| 100 | MP0005310_abnormal_salivary_gland | 0.82812943 |
| 101 | MP0001730_embryonic_growth_arrest | 0.82321865 |
| 102 | MP0000604_amyloidosis | 0.81959426 |
| 103 | MP0003075_altered_response_to | 0.81808370 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.81160342 |
| 105 | MP0009763_increased_sensitivity_to | 0.80924125 |
| 106 | MP0005166_decreased_susceptibility_to | 0.80194677 |
| 107 | MP0008775_abnormal_heart_ventricle | 0.77925054 |
| 108 | MP0002009_preneoplasia | 0.76877158 |
| 109 | MP0001544_abnormal_cardiovascular_syste | 0.76682433 |
| 110 | MP0005385_cardiovascular_system_phenoty | 0.76682433 |
| 111 | MP0003448_altered_tumor_morphology | 0.76305412 |
| 112 | MP0002106_abnormal_muscle_physiology | 0.75786978 |
| 113 | MP0009840_abnormal_foam_cell | 0.73419696 |
| 114 | MP0010307_abnormal_tumor_latency | 0.71734364 |
| 115 | MP0006054_spinal_hemorrhage | 0.71281360 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.70451791 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.70052469 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.69987288 |
| 119 | MP0003045_fibrosis | 0.69766529 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.69182703 |
| 121 | MP0005076_abnormal_cell_differentiation | 0.68517419 |
| 122 | MP0003984_embryonic_growth_retardation | 0.68188658 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.67918617 |
| 124 | MP0004147_increased_porphyrin_level | 0.67192331 |
| 125 | MP0002088_abnormal_embryonic_growth/wei | 0.66346187 |
| 126 | MP0002095_abnormal_skin_pigmentation | 0.64371875 |
| 127 | MP0008004_abnormal_stomach_pH | 0.63233590 |
| 128 | MP0000249_abnormal_blood_vessel | 0.61317601 |
| 129 | MP0008874_decreased_physiological_sensi | 0.60584910 |
| 130 | MP0003795_abnormal_bone_structure | 0.60246547 |
| 131 | MP0005390_skeleton_phenotype | 0.57999868 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.57406594 |
| 133 | MP0004484_altered_response_of | 0.53945426 |
| 134 | MP0003806_abnormal_nucleotide_metabolis | 0.53873862 |
| 135 | MP0005164_abnormal_response_to | 0.53664020 |
| 136 | MP0009115_abnormal_fat_cell | 0.52398315 |
| 137 | MP0004145_abnormal_muscle_electrophysio | 0.51714016 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.49086777 |
| 139 | MP0005381_digestive/alimentary_phenotyp | 0.47893827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.99288553 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.60115891 |
| 3 | Nasal polyposis (HP:0100582) | 5.63185715 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 5.26879433 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.15847696 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.92268765 |
| 7 | Recurrent viral infections (HP:0004429) | 4.90610969 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 4.84564749 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 4.77692883 |
| 10 | Abnormality of T cells (HP:0002843) | 4.70170551 |
| 11 | Recurrent bronchitis (HP:0002837) | 4.67675399 |
| 12 | Combined immunodeficiency (HP:0005387) | 4.61069989 |
| 13 | Abnormality of B cell number (HP:0010975) | 4.38798948 |
| 14 | B lymphocytopenia (HP:0010976) | 4.38798948 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.15342101 |
| 16 | Obstructive lung disease (HP:0006536) | 4.15342101 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.03970102 |
| 18 | Chronic otitis media (HP:0000389) | 4.01639750 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.94001792 |
| 20 | Orchitis (HP:0100796) | 3.92756145 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.90362223 |
| 22 | Thyroiditis (HP:0100646) | 3.88975926 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82322532 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.80959732 |
| 25 | Optic neuritis (HP:0100653) | 3.80959732 |
| 26 | Abnormality of the fingertips (HP:0001211) | 3.80441491 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 3.78461640 |
| 28 | IgM deficiency (HP:0002850) | 3.62167397 |
| 29 | Eosinophilia (HP:0001880) | 3.61389076 |
| 30 | Pustule (HP:0200039) | 3.55877266 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.48087415 |
| 32 | Papilloma (HP:0012740) | 3.29507455 |
| 33 | Verrucae (HP:0200043) | 3.29507455 |
| 34 | Bronchitis (HP:0012387) | 3.27613286 |
| 35 | Hypoplasia of the thymus (HP:0000778) | 3.22861037 |
| 36 | IgG deficiency (HP:0004315) | 3.21217149 |
| 37 | Abnormality of eosinophils (HP:0001879) | 3.19530621 |
| 38 | Granulocytopenia (HP:0001913) | 3.14709982 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.10483173 |
| 40 | Gingivitis (HP:0000230) | 3.00377536 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 2.97759973 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.96293874 |
| 43 | Prolonged bleeding time (HP:0003010) | 2.95987390 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86918587 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86918587 |
| 46 | Urticaria (HP:0001025) | 2.86758407 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.86054709 |
| 48 | Keratoconjunctivitis sicca (HP:0001097) | 2.81306850 |
| 49 | Meningitis (HP:0001287) | 2.81172842 |
| 50 | Basal cell carcinoma (HP:0002671) | 2.81055193 |
| 51 | Recurrent sinusitis (HP:0011108) | 2.78459844 |
| 52 | Leukocytosis (HP:0001974) | 2.76916822 |
| 53 | Subaortic stenosis (HP:0001682) | 2.76200515 |
| 54 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.76200515 |
| 55 | Abnormal number of erythroid precursors (HP:0012131) | 2.76187372 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.75883845 |
| 57 | Bronchiectasis (HP:0002110) | 2.74507860 |
| 58 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.67690724 |
| 59 | Agammaglobulinemia (HP:0004432) | 2.67298952 |
| 60 | Myositis (HP:0100614) | 2.65072908 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.62042608 |
| 62 | Lymphopenia (HP:0001888) | 2.59919601 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.58857147 |
| 64 | Recurrent otitis media (HP:0000403) | 2.58487449 |
| 65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.56468607 |
| 66 | Chronic sinusitis (HP:0011109) | 2.50812648 |
| 67 | Petechiae (HP:0000967) | 2.48848712 |
| 68 | Osteomyelitis (HP:0002754) | 2.47495997 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.47045386 |
| 70 | Exercise-induced myalgia (HP:0003738) | 2.44448641 |
| 71 | Arterial thrombosis (HP:0004420) | 2.43695226 |
| 72 | Increased IgM level (HP:0003496) | 2.42317523 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.41159940 |
| 74 | Stomatitis (HP:0010280) | 2.40603276 |
| 75 | Exercise-induced muscle cramps (HP:0003710) | 2.37757616 |
| 76 | Colitis (HP:0002583) | 2.37694709 |
| 77 | Pulmonary embolism (HP:0002204) | 2.36854220 |
| 78 | Polycythemia (HP:0001901) | 2.36742581 |
| 79 | Lymphoma (HP:0002665) | 2.35552244 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.33889487 |
| 81 | Bicuspid aortic valve (HP:0001647) | 2.33720187 |
| 82 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.33442433 |
| 83 | Thrombocytosis (HP:0001894) | 2.32706879 |
| 84 | Cellulitis (HP:0100658) | 2.28963117 |
| 85 | Recurrent abscess formation (HP:0002722) | 2.27628420 |
| 86 | Eczematoid dermatitis (HP:0000976) | 2.26464743 |
| 87 | Ventricular tachycardia (HP:0004756) | 2.26445657 |
| 88 | Increased IgE level (HP:0003212) | 2.24065708 |
| 89 | Sudden death (HP:0001699) | 2.24043727 |
| 90 | Increased serum ferritin (HP:0003281) | 2.23834766 |
| 91 | Epistaxis (HP:0000421) | 2.22994474 |
| 92 | Gingival bleeding (HP:0000225) | 2.22731227 |
| 93 | Gastrointestinal stroma tumor (HP:0100723) | 2.21119113 |
| 94 | Hypoproteinemia (HP:0003075) | 2.20016189 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19358394 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19358394 |
| 97 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19358394 |
| 98 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.14761030 |
| 99 | Absent/shortened dynein arms (HP:0200106) | 2.14761030 |
| 100 | Anorexia (HP:0002039) | 2.12339407 |
| 101 | Episodic fever (HP:0001954) | 2.11996791 |
| 102 | Sepsis (HP:0100806) | 2.11733195 |
| 103 | Encephalitis (HP:0002383) | 2.11294623 |
| 104 | Slow saccadic eye movements (HP:0000514) | 2.11118492 |
| 105 | Purpura (HP:0000979) | 2.10823500 |
| 106 | Abnormal platelet volume (HP:0011876) | 2.08512355 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 2.07033687 |
| 108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05493706 |
| 109 | Hypertensive crisis (HP:0100735) | 2.05354460 |
| 110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.04781287 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 2.03282686 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.02689082 |
| 113 | Abnormality of the endocardium (HP:0004306) | 2.02523698 |
| 114 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.00995631 |
| 115 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.99517393 |
| 116 | Fatigue (HP:0012378) | 1.97482191 |
| 117 | Rhabdomyolysis (HP:0003201) | 1.96443311 |
| 118 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.96427463 |
| 119 | Chronic diarrhea (HP:0002028) | 1.96111401 |
| 120 | Poikilocytosis (HP:0004447) | 1.94485381 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.93869276 |
| 122 | Abnormal platelet function (HP:0011869) | 1.93869276 |
| 123 | Viral hepatitis (HP:0006562) | 1.91518577 |
| 124 | Chest pain (HP:0100749) | 1.90570116 |
| 125 | Skin ulcer (HP:0200042) | 1.90193923 |
| 126 | Broad palm (HP:0001169) | 1.87806388 |
| 127 | Myoglobinuria (HP:0002913) | 1.87725047 |
| 128 | Prominent nose (HP:0000448) | 1.87677377 |
| 129 | Restrictive lung disease (HP:0002091) | 1.87253484 |
| 130 | Lipoatrophy (HP:0100578) | 1.86426202 |
| 131 | Hypochromic anemia (HP:0001931) | 1.85084925 |
| 132 | Dysostosis multiplex (HP:0000943) | 1.83992445 |
| 133 | Polyneuropathy (HP:0001271) | 1.83654342 |
| 134 | Recurrent skin infections (HP:0001581) | 1.82327671 |
| 135 | Calf muscle hypertrophy (HP:0008981) | 1.81436978 |
| 136 | Vasculitis (HP:0002633) | 1.79844325 |
| 137 | Reticulocytosis (HP:0001923) | 1.79288755 |
| 138 | Poikiloderma (HP:0001029) | 1.79160527 |
| 139 | Hyporeflexia of lower limbs (HP:0002600) | 1.77098839 |
| 140 | Joint swelling (HP:0001386) | 1.76282373 |
| 141 | Increased density of long bones (HP:0006392) | 1.76209165 |
| 142 | Easy fatigability (HP:0003388) | 1.74772029 |
| 143 | Microcytic anemia (HP:0001935) | 1.74488755 |
| 144 | Abnormality of reticulocytes (HP:0004312) | 1.74183121 |
| 145 | Hemoptysis (HP:0002105) | 1.70714901 |
| 146 | Frequent falls (HP:0002359) | 1.67301384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.30774031 |
| 2 | RIPK4 | 4.71698710 |
| 3 | TXK | 3.57453830 |
| 4 | MAP3K10 | 3.44564369 |
| 5 | PRPF4B | 3.31330341 |
| 6 | EEF2K | 3.20816614 |
| 7 | PKN2 | 2.91654466 |
| 8 | GRK6 | 2.71748852 |
| 9 | STK10 | 2.57444212 |
| 10 | ZAP70 | 2.56061008 |
| 11 | ITK | 2.51289582 |
| 12 | JAK3 | 2.31035739 |
| 13 | TYK2 | 2.13122601 |
| 14 | TAOK3 | 2.07327979 |
| 15 | FGFR4 | 1.91433513 |
| 16 | TRIB3 | 1.86886190 |
| 17 | PDK3 | 1.71678766 |
| 18 | PDK4 | 1.71678766 |
| 19 | TTN | 1.62922631 |
| 20 | IKBKE | 1.62141096 |
| 21 | BTK | 1.57661050 |
| 22 | NLK | 1.50614571 |
| 23 | NME2 | 1.49472334 |
| 24 | CDK12 | 1.49376876 |
| 25 | SYK | 1.48437529 |
| 26 | FGFR3 | 1.47944791 |
| 27 | LCK | 1.45897386 |
| 28 | TEC | 1.45079932 |
| 29 | STK4 | 1.40328124 |
| 30 | FLT3 | 1.37870393 |
| 31 | KSR2 | 1.36275181 |
| 32 | NEK2 | 1.36180281 |
| 33 | JAK1 | 1.27154224 |
| 34 | LRRK2 | 1.23418865 |
| 35 | HCK | 1.18754243 |
| 36 | MAP3K7 | 1.15934371 |
| 37 | MAP3K1 | 1.15919820 |
| 38 | STK24 | 1.14881731 |
| 39 | CDK4 | 1.13804244 |
| 40 | PIM1 | 1.11952731 |
| 41 | CLK1 | 1.08904808 |
| 42 | FGR | 1.08027904 |
| 43 | TESK1 | 1.06950655 |
| 44 | CSK | 1.06457863 |
| 45 | MAP3K3 | 1.05771864 |
| 46 | TBK1 | 1.05444357 |
| 47 | MAP2K3 | 1.00693147 |
| 48 | PRKCQ | 0.99682585 |
| 49 | SIK3 | 0.99619905 |
| 50 | MARK3 | 0.99505758 |
| 51 | PIK3CG | 0.97322889 |
| 52 | ICK | 0.94980834 |
| 53 | SIK2 | 0.94507401 |
| 54 | KDR | 0.93164159 |
| 55 | CDC7 | 0.92813466 |
| 56 | BMPR2 | 0.92574328 |
| 57 | PRKCH | 0.88608852 |
| 58 | TGFBR2 | 0.87877289 |
| 59 | KIT | 0.86425907 |
| 60 | CSF1R | 0.85500708 |
| 61 | JAK2 | 0.84046077 |
| 62 | TAOK2 | 0.83823353 |
| 63 | DMPK | 0.81227784 |
| 64 | PDK1 | 0.80453972 |
| 65 | RPS6KA4 | 0.79289632 |
| 66 | MST4 | 0.78938630 |
| 67 | SMG1 | 0.75969161 |
| 68 | TNK2 | 0.75028164 |
| 69 | BLK | 0.73841183 |
| 70 | MAPK12 | 0.73681252 |
| 71 | MAP3K13 | 0.73419978 |
| 72 | RPS6KB2 | 0.71317877 |
| 73 | MATK | 0.71166781 |
| 74 | PDPK1 | 0.67750243 |
| 75 | MAP3K14 | 0.66430329 |
| 76 | YES1 | 0.65574949 |
| 77 | CDC42BPA | 0.65462810 |
| 78 | MAPK11 | 0.64316931 |
| 79 | TRPM7 | 0.62720062 |
| 80 | IKBKB | 0.61210887 |
| 81 | CAMKK2 | 0.61094480 |
| 82 | PRKD2 | 0.59504949 |
| 83 | PDK2 | 0.58743024 |
| 84 | HIPK2 | 0.58087558 |
| 85 | DYRK1B | 0.57394317 |
| 86 | PDGFRB | 0.57186403 |
| 87 | LYN | 0.56978774 |
| 88 | MARK2 | 0.56439365 |
| 89 | PASK | 0.55985037 |
| 90 | TAOK1 | 0.54556616 |
| 91 | CAMKK1 | 0.53050462 |
| 92 | TESK2 | 0.52715516 |
| 93 | MAPK7 | 0.51033629 |
| 94 | RAF1 | 0.50920594 |
| 95 | FES | 0.50734643 |
| 96 | STK11 | 0.50027738 |
| 97 | ATR | 0.49792206 |
| 98 | FYN | 0.49475043 |
| 99 | MAP3K8 | 0.48145153 |
| 100 | RET | 0.48013323 |
| 101 | MYLK | 0.47957632 |
| 102 | TYRO3 | 0.47526539 |
| 103 | MELK | 0.46079972 |
| 104 | RPS6KA6 | 0.45965076 |
| 105 | MAP3K2 | 0.45731691 |
| 106 | CDK6 | 0.44679790 |
| 107 | EPHB1 | 0.43732181 |
| 108 | DYRK3 | 0.42489930 |
| 109 | IRAK1 | 0.42221071 |
| 110 | ILK | 0.41253247 |
| 111 | RPS6KL1 | 0.40949193 |
| 112 | RPS6KC1 | 0.40949193 |
| 113 | ALK | 0.40401829 |
| 114 | MAP2K2 | 0.40210608 |
| 115 | GRK7 | 0.39802928 |
| 116 | PTK6 | 0.38352725 |
| 117 | BRD4 | 0.37746487 |
| 118 | MAP2K6 | 0.37405703 |
| 119 | MAPK4 | 0.37295186 |
| 120 | CHEK1 | 0.37194707 |
| 121 | MAP3K6 | 0.36727624 |
| 122 | IRAK4 | 0.35715767 |
| 123 | CDK19 | 0.35350370 |
| 124 | SGK3 | 0.35267440 |
| 125 | OBSCN | 0.35119149 |
| 126 | TGFBR1 | 0.32407008 |
| 127 | STK38 | 0.32315041 |
| 128 | MAP3K11 | 0.32227945 |
| 129 | PTK2B | 0.31751879 |
| 130 | PRKD1 | 0.30681249 |
| 131 | ERN1 | 0.29432655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.61565723 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.36056820 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55346292 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.54964707 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.48695831 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.42790230 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21654629 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07999739 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 1.98727397 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96293859 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92452898 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91893023 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.90077621 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.88677939 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82008771 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.79657797 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74213082 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.73283417 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.71543102 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.68986057 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.68926223 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64586646 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51298976 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.49628831 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43385738 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41620100 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41562423 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.40441663 |
| 29 | Mismatch repair_Homo sapiens_hsa03430 | 1.31307417 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28486981 |
| 31 | Spliceosome_Homo sapiens_hsa03040 | 1.28235586 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28143688 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23221742 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.18984778 |
| 35 | HTLV-I infection_Homo sapiens_hsa05166 | 1.18092235 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15891402 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.13293383 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.08602805 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07071878 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.05729451 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04133109 |
| 42 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02821523 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00856742 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99897532 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.98881672 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96745040 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93816829 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93623655 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.93028170 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92870267 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.92305690 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91821259 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 0.91172111 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90893734 |
| 55 | RNA degradation_Homo sapiens_hsa03018 | 0.90427299 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89468374 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88919882 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87570950 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.84466439 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.84144744 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.82582655 |
| 62 | RNA transport_Homo sapiens_hsa03013 | 0.81099705 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79107995 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78717956 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77570944 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76670501 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.76181027 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.73793676 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.72681086 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72640092 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72525978 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72165976 |
| 73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71967898 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.71648849 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70906483 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70262580 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69569286 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68784278 |
| 79 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68600204 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67827020 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66951776 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66868728 |
| 83 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66696595 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66692541 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65371819 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64535905 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64460980 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64187847 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64159204 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63446738 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63183380 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63071751 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62890659 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62832095 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62353867 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60448716 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59621192 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57963682 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56628546 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56572442 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55559277 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54006989 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52075607 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51823622 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50373131 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49713854 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49422315 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48997518 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48293026 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48034787 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46691055 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46264315 |
| 113 | Tuberculosis_Homo sapiens_hsa05152 | 0.45990479 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45920393 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45828819 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45306443 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44247156 |
| 118 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.43668378 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.43530336 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42829386 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.41723206 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41047534 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.39640000 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39257668 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38844075 |
| 126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37799788 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37682154 |
| 128 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37000382 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35904741 |
| 130 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35870895 |
| 131 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35541822 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.35150396 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34152215 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32921221 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.31396761 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.31381043 |

